Medicare AdvantagePrior AuthMedium impact
MA08.186a, Penpulimab-kcqx
Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Jun 1, 2026
We identified it
Jun 19, 2026
Summary
Medical necessity criteria for Penpulimab-kcqx (a pharmacy benefit drug) have been updated for Medicare Advantage plans. This affects coverage determination and prior authorization requirements for this medication.
Action Required
By June 1, 2026: Billing team and providers must review updated medical necessity criteria for Penpulimab-kcqx prescriptions. Update prior authorization workflows to comply with new Medicare Advantage requirements. Ensure documentation meets revised criteria to avoid coverage denials.